ABBOTT LABORATORIES

ABT

ABBOTT LABORATORIES

ABT

Insider Sentiment (TTM):

Last Purchase:2026-05-07Last Sale:2026-03-02Shares Purchased (TTM):43,000Shares Sold (TTM):11,335

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:1,297,494,961Shares Outstanding:1,742,480,000Institutional Ownership Pct.:74.46%

Earnings Market Reaction:

Filing Date:2026-04-29Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Pharmaceutical Preparations

LLY JNJ ABBV MRK PFE BMY

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	6,803	8,522	7,511	6,951	6,532	7,616	7,558	6,987	6,284	6,896	6,709	7,835
Short Term Investments	492	417	222	331	312	351	230	232	367	383	338	320
Accounts Receivable Net Current	8,210	7,929	8,138	7,972	7,327	6,925	7,051	6,854	6,605	6,565	6,499	6,172
Inventory Net
Inventory Finished Goods Net Of Reserves	4,274	3,976	4,130	4,319	4,063	3,700	4,173	4,060	4,063	3,946	3,847	4,004
Inventory Work In Process Net Of Reserves	994	904	961	962	890	840	877	880	881	807	888	845
Inventory Raw Materials Net Of Reserves	1,721	1,608	1,617	1,673	1,686	1,654	1,763	1,874	1,883	1,817	1,915	2,022
Inventory Net	6,989	6,488	6,708	6,954	6,639	6,194	6,813	6,814	6,827	6,570	6,650	6,871
Assets Current	25,508	25,996	24,839	24,468	23,153	23,656	23,802	23,119	22,376	22,670	22,664	23,505
Long Term Investments	1,090	918	951	958	907	886	912	877	818	799	788	799
Property Plant And Equipm…
Land	-	541	-	-	-	528	-	-	-	529	-	-
Buildings And Improvements Gross	-	4,543	-	-	-	4,207	-	-	-	4,161	-	-
Machinery And Equipment Gross	-	17,571	-	-	-	15,517	-	-	-	15,179	-	-
Construction In Progress Gross	-	2,567	-	-	-	2,488	-	-	-	2,064	-	-
Property Plant And Equipment Gross	25,737	25,222	24,816	24,472	23,418	22,740	22,857	22,061	22,055	21,933	21,111	20,926
Accumulated Depreciation Depletion And Amortizatio…	13,360	13,406	13,312	13,077	12,486	12,082	12,236	11,828	11,948	11,779	11,559	11,477
Property Plant And Equipment Net	12,377	11,816	11,504	11,395	10,932	10,658	10,621	10,233	10,107	10,154	9,552	9,449
Intangible Assets Net Excluding Goodwill	17,875	5,526	5,598	5,920	6,261	6,647	7,352	7,827	8,296	8,815	9,282	9,834
Goodwill	35,221	24,035	23,971	23,952	23,359	23,108	23,658	23,308	23,383	23,679	23,277	23,258
Deferred Income Taxes And Other Assets Noncurrent	18,358	18,422	17,318	17,306	16,836	16,459	8,011	7,653	7,487	7,097	6,527	6,509
Assets	110,429	86,713	84,181	83,999	81,448	81,414	74,356	73,017	72,467	73,214	72,090	73,354
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Trade Current	4,679	4,240	4,123	4,306	4,214	4,195	4,034	4,125	4,178	4,295	3,961	4,211
Employee Related Liabilities Current	1,212	1,745	1,735	1,550	1,167	1,701	1,618	1,389	1,092	1,597	1,479	1,362
Other Accrued Liabilities Current	6,379	5,812	5,880	5,656	5,600	5,143	5,427	5,071	5,220	5,422	5,347	5,334
Dividends Payable Current	1,100	1,097	1,030	1,030	1,032	1,024	956	959	959	955	886	886
Accrued Income Taxes Current	598	569	469	390	485	594	713	601	562	492	318	273
Long Term Debt Current	4,409	3,033	1,345	507	506	1,500	2,154	1,615	2,010	1,080	1,051	2,284
Liabilities Current	18,377	16,496	14,582	13,439	13,004	14,157	14,902	13,760	14,021	13,841	13,042	14,350
Long Term Debt Noncurrent	29,638	9,896	11,596	12,930	12,736	12,625	12,825	13,139	12,576	13,599	14,477	14,562
Stockholders Equity Inclu…
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Value	25,352	25,527	25,412	25,284	25,125	25,153	25,020	24,858	24,726	24,869	24,727	24,612
Treasury Stock Common Value	-16,935	-17,177	-16,877	-16,610	-16,612	-16,844	-16,476	-15,759	-15,761	-15,981	-15,686	-15,722
Retained Earnings Accumulated Deficit	49,956	49,781	49,103	48,467	47,715	47,261	39,056	38,354	38,011	37,554	36,920	36,355
Accumulated Other Comprehensive Income Loss Net Of…	-6,312	-6,001	-6,684	-6,576	-7,417	-7,906	-7,804	-8,135	-8,166	-7,839	-8,480	-8,071
Stockholders Equity	52,061	52,771	51,264	50,829	48,811	47,901	39,796	39,318	39,043	38,827	37,694	37,404
Minority Interest	640	641	310	264	253	237	232	242	233	224	213	230
Liabilities And Stockholders Equity	110,429	86,713	84,181	83,999	81,448	81,414	74,356	73,017	72,467	73,214	72,090	73,354
Allowance For Doubtful Accounts Receivable Current	494	490	490	471	449	439	456	441	439	444	472	485
Preferred Stock Par Or Stated Value Per Share	1	1	1	1	1	1	1	1	1	1	1	1
Preferred Stock Shares Authorized	1	1	1	1	1	1	1	1	1	1	1	1
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	2,400	2,400	2,400	2,400	2,400	2,400	2,400	2,400	2,400	2,400	2,400	2,400
Common Stock Shares Issued	1,998	1,997	1,997	1,996	1,996	1,991	1,991	1,990	1,990	1,988	1,987	1,987
Treasury Stock Common Shares	256	260	258	256	256	260	257	250	250	254	251	252

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-4.29%	-3.20%	-	-	-	-	-	-	-	-	-	-
2025	0.42%	1.71%	-4.99%	3.14%	5.83%	0.44%	2.96%	0.82%	-1.65%	-3.73%	-10.61%	-24.38%
2024	-1.86%	-0.19%	-3.16%	6.37%	7.32%	13.23%	3.87%	0.76%	0.62%	-6.09%	-5.96%	-0.79%
2023	-7.21%	-2.53%	3.59%	-3.10%	-8.73%	-9.51%	8.27%	14.76%	21.30%	6.10%	-2.46%	-6.65%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 50+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Liquidity Ratios
Current Ratio	1.39	1.58	1.70	1.82	1.78	1.67	1.60	1.68	1.60	1.64	1.74	1.64
Quick Ratio	1.01	1.18	1.24	1.30	1.27	1.23	1.14	1.18	1.11	1.16	1.23	1.16
Working Capital	7.13B	9.50B	10.26B	11.03B	10.15B	9.50B	8.90B	9.36B	8.36B	8.83B	9.62B	9.16B
Leverage & Debt
Debt to Equity	0.35	0.31	0.28	0.26	0.27	0.30	0.37	0.35	0.36	0.36	0.35	0.38
Interest Coverage TTM	14.38	16.33	15.15	14.18	12.99	12.21	11.50	10.70	10.17	10.17	9.50	10.09
Debt Ratio	0.17	0.19	0.17	0.16	0.16	0.17	0.20	0.19	0.19	0.19	0.18	0.20
Efficiency & Turnover
Asset Turnover TTM	0.47	0.53	0.55	0.55	0.55	0.54	0.56	0.56	0.55	0.54	0.55	0.55
Days Sales Outstanding TTM	62.82	61.15	63.23	62.77	60.05	58.69	60.00	58.37	57.14	58.16	58.95	60.66
Receivables Turnover TTM	5.81	5.97	5.77	5.82	6.08	6.22	6.08	6.25	6.39	6.28	6.19	6.02
Per Share Metrics
Diluted EPS TTM	3.59	3.73	7.99	7.98	7.73	7.67	3.30	3.17	3.22	3.27	2.95	2.95
Free Cash Flow Per Share TTM	4.23	4.25	3.97	3.89	3.83	3.65	3.73	3.24	2.83	2.91	2.58	3.15
Dividend Per Share TTM	2.40	2.36	2.32	2.28	2.25	2.20	2.17	2.12	2.08	2.04	2.01	1.97
Margin Metrics
Gross Profit Margin TTM	56.26%	56.42%	55.89%	56.01%	55.81%	55.41%	55.55%	55.24%	55.10%	55.18%	54.92%	55.16%
Operating Profit Margin TTM	17.07%	18.17%	17.59%	17.43%	16.84%	16.27%	16.24%	15.92%	15.76%	16.15%	15.02%	15.23%
Net Profit Margin TTM	13.91%	14.72%	31.88%	32.43%	31.89%	31.95%	13.99%	13.65%	13.96%	14.27%	12.92%	12.83%
Growth Metrics
Net Revenue Growth (1Y)	6.59%	5.67%	6.37%	5.85%	5.00%	4.59%	3.15%	1.24%	-2.84%	-8.12%	-11.26%	-11.68%
Net Income Growth (1Y)	-53.52%	-51.32%	142.36%	151.56%	139.82%	134.18%	11.72%	7.67%	-3.00%	-17.45%	-52.52%	-55.26%
EPS Growth (1Y)	-53.61%	-51.35%	141.99%	151.50%	139.96%	134.18%	11.67%	7.51%	-2.91%	-16.84%	-52.13%	-54.91%
Valuation Metrics
P/E TTM	28.13	32.82	16.32	16.51	16.55	14.15	32.98	31.09	33.35	31.61	30.65	34.37
P/B TTM	3.39	4.06	4.45	4.54	4.58	3.96	4.78	4.39	4.81	4.66	4.20	4.74
P/S TTM	3.91	4.83	5.20	5.35	5.28	4.52	4.61	4.24	4.66	4.51	3.96	4.41
Market Cap	176.53B	214.15B	228.07B	230.73B	223.45B	189.63B	190.18B	172.77B	187.75B	180.92B	158.20B	177.39B
Enterprise Value	203.77B	218.56B	233.50B	237.22B	230.16B	196.14B	197.60B	180.54B	196.05B	188.70B	167.02B	186.41B
Calculated Values
Free Cash Flow TTM	7.38B	7.40B	6.92B	6.78B	6.66B	6.35B	6.49B	5.65B	4.92B	5.06B	4.49B	5.49B
Net Debt	27.24B	4.41B	5.43B	6.49B	6.71B	6.51B	7.42B	7.77B	8.30B	7.78B	8.82B	9.01B
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-05-07Purchase

Owner: Stratton, John G

Title: -

Shares: 2,000

Price/Share: $86.82

Value: $173,640.00

Shares Owned: 23,319

Relationship: Director

Ownership: Direct

2026-04-27Purchase

Owner: Starks, Daniel J

Title: -

Shares: 10,000

Price/Share: $92.65

Value: $926,500.00

Shares Owned: 6,751,103

Relationship: Director

Ownership: Direct

2026-04-23Purchase

Owner: Boudreau, Philip P

Title: EVP AND CFO

Shares: 2,200

Price/Share: $91.50

Value: $201,300.00

Shares Owned: 2,200

Relationship: Officer

Ownership: Indirect

2026-03-02Sale

Owner: Morrone, Louis H.

Title: EXECUTIVE VICE PRESIDENT

Shares: 1,144

Price/Share: $115.58

Value: $132,223.52

Shares Owned: 76,843

Relationship: Officer

Ownership: Direct

2026-03-02Sale

Owner: Moreland, Mary K

Title: EXECUTIVE VICE PRESIDENT

Shares: 613

Price/Share: $115.58

Value: $70,850.54

Shares Owned: 104,291

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-05-07	Stratton, John G	Director	-	Direct	Purchase	2,000	86.82	$173,640.00	23,319	4
2026-04-27	Starks, Daniel J	Director	-	Direct	Purchase	10,000	92.65	$926,500.00	6,751,103	4
2026-04-23	Boudreau, Philip P	Officer	EVP AND CFO	Indirect	Purchase	2,200	91.50	$201,300.00	2,200	4
2026-03-02	Morrone, Louis H.	Officer	EXECUTIVE VICE PRESIDENT	Direct	Sale	1,144	115.58	$132,223.52	76,843	4
2026-03-02	Moreland, Mary K	Officer	EXECUTIVE VICE PRESIDENT	Direct	Sale	613	115.58	$70,850.54	104,291	4
2026-03-02	Mccoy, John A. Jr.	Officer	VICE PRESIDENT AND CONTROLLER	Direct	Sale	585	115.58	$67,614.30	24,628	4
2026-03-02	Cushman, Elizabeth C.	Officer	EVP, GC AND SECRETARY	Direct	Sale	263	115.58	$30,397.54	38,573	4
2026-03-02	Shroff, Eric	Officer	Senior Vice President	Direct	Sale	709	115.58	$81,946.22	39,164	4
2026-03-02	Salvadori, Daniel Gesua S…	Officer	EVP AND GROUP PRESIDENT	Direct	Sale	885	115.58	$102,288.30	146,377	4
2026-02-04	Starks, Daniel J	Director	-	Direct	Purchase	10,000	108.74	$1,087,400.00	6,738,817	4
2026-01-23	Ford, Robert B	Director,Officer	CHAIRMAN AND CEO	Indirect	Purchase	18,800	107.13	$2,014,044.00	216,203	4
2025-11-25	Shroff, Eric	Officer	Senior Vice President	Direct	Sale	1,586	128.02	$203,039.72	30,384	4
2025-08-08	Boudreau, Philip P	Officer	EVP AND CFO	Direct	Sale	5,550	134.55	$746,752.50	51,003	4
2025-04-30	Blount, Sally E.	Director	-	Direct	Sale	2,600	129.66	$337,116.00	34,058	4
2025-03-06	Earnhardt, Lisa D	Officer	EVP AND GROUP PRESIDENT	Direct	Sale	91,167	133.82	$12,199,967.94	71,928	4
2025-03-03	Morrone, Louis H.	Officer	EXECUTIVE VICE PRESIDENT	Direct	Sale	1,111	138.17	$153,506.87	66,878	4
2025-03-03	Moreland, Mary K	Officer	EXECUTIVE VICE PRESIDENT	Direct	Sale	791	138.17	$109,292.47	95,583	4
2025-03-03	Shroff, Eric	Officer	Senior Vice President	Direct	Sale	562	138.17	$77,651.54	31,970	4
2025-03-03	Wainer, Andrea F	Officer	RETIRED EVP	Direct	Sale	949	138.17	$131,123.33	74,381	4
2025-03-03	Mccoy, John A. Jr.	Officer	VICE PRESIDENT AND CONTROLLER	Direct	Sale	562	138.17	$77,651.54	21,061	4
2025-02-05	Ford, Robert B	Director,Officer	CHAIRMAN AND CEO	Direct	Sale	285,388	131.17	$37,434,343.96	220,059	4
2025-01-30	Allen, Hubert L	Officer	EXECUTIVE VICE PRESIDENT	Direct	Sale	58,428	128.07	$7,482,873.96	184,806	4
2025-01-30	Salvadori, Daniel Gesua S…	Officer	EXECUTIVE VICE PRESIDENT	Direct	Sale	23,771	128.50	$3,054,573.50	125,697	4
2025-01-28	Morrone, Louis H.	Officer	EXECUTIVE VICE PRESIDENT	Indirect	Sale	2,644	127.39	$336,819.16	0	4
2024-10-21	Allen, Hubert L	Officer	EXECUTIVE VICE PRESIDENT	Direct	Sale	157,421	117.98	$18,572,529.58	184,806	4
2024-09-12	Ford, Robert B	Director,Officer	CHAIRMAN AND CEO	Direct	Sale	141,679	116.47	$16,501,353.13	220,059	4
2024-09-04	Mccoy, John A. Jr.	Officer	VICE PRESIDENT	Direct	Sale	27	114.83	$3,100.41	18,681	4
2024-05-10	Funck,, Jr. Robert E.	Officer	EXECUTIVE VICE PRESIDENT	Direct	Sale	10,097	104.57	$1,055,843.29	211,341	4
2024-05-07	Earnhardt, Lisa D	Officer	EXECUTIVE VICE PRESIDENT	Direct	Sale	22,852	106.25	$2,428,025.00	61,462	4
2024-03-01	Morrone, Louis H.	Officer	EXECUTIVE VICE PRESIDENT	Direct	Sale	801	118.50	$94,918.50	62,968	4
2024-03-01	Moreland, Mary K	Officer	EXECUTIVE VICE PRESIDENT	Direct	Sale	676	118.50	$80,106.00	91,260	4
2024-03-01	Allen, Hubert L	Officer	EXECUTIVE VICE PRESIDENT	Direct	Sale	853	118.50	$101,080.50	184,806	4
2024-03-01	Salvadori, Daniel Gesua S…	Officer	EXECUTIVE VICE PRESIDENT	Direct	Sale	963	118.50	$114,115.50	125,697	4
2024-03-01	Earnhardt, Lisa D	Officer	EXECUTIVE VICE PRESIDENT	Direct	Sale	694	118.50	$82,239.00	84,314	4
2024-03-01	Mccoy, John A. Jr.	Officer	VICE PRESIDENT	Direct	Sale	472	118.50	$55,932.00	18,760	4
2024-02-23	Wainer, Andrea F	Officer	EXECUTIVE VICE PRESIDENT	Direct	Sale	12,500	120.00	$1,500,000.00	78,704	4
2024-01-29	Wainer, Andrea F	Officer	EXECUTIVE VICE PRESIDENT	Direct	Sale	42,500	112.50	$4,781,250.00	65,027	4
2023-12-14	Wainer, Andrea F	Officer	EXECUTIVE VICE PRESIDENT	Direct	Sale	15,000	108.00	$1,620,000.00	65,027	4
2023-10-26	Starks, Daniel J	Director	-	Direct	Sale	50,000	94.07	$4,703,500.00	6,725,316	4
2023-08-08	Wainer, Andrea F	Officer	EXECUTIVE VICE PRESIDENT	Direct	Sale	10,400	105.95	$1,101,880.00	65,027	4
2023-07-27	Starks, Daniel J	Director	-	Direct	Sale	50,000	113.72	$5,686,000.00	6,775,316	4
2023-06-16	Boudreau, Philip P	Officer	VICE PRESIDENT	Direct	Sale	8,000	106.00	$848,000.00	15,447	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

74.46%

Inst. Shares: 1,297,494,961

Shares Outstanding: 1,742,480,000

2025-12-31

75.51%

Inst. Shares: 1,314,670,310

Shares Outstanding: 1,741,000,000

2025-09-30

73.72%

Inst. Shares: 1,284,387,184

Shares Outstanding: 1,742,142,000

2025-06-30

75.08%

Inst. Shares: 1,309,005,866

Shares Outstanding: 1,743,437,000

2025-03-31

74.10%

Inst. Shares: 1,288,836,541

Shares Outstanding: 1,739,206,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	1,297,494,961	1,742,480,000	74.46%
2025-12-31	1,314,670,310	1,741,000,000	75.51%
2025-09-30	1,284,387,184	1,742,142,000	73.72%
2025-06-30	1,309,005,866	1,743,437,000	75.08%
2025-03-31	1,288,836,541	1,739,206,000	74.10%
2024-12-31	1,289,603,872	1,740,000,000	74.12%
2024-09-30	1,233,585,324	1,739,466,000	70.92%
2024-06-30	1,261,690,796	1,743,040,000	72.38%
2024-03-31	1,228,671,649	1,740,203,000	70.61%
2023-12-31	1,245,507,560	1,740,000,000	71.58%
2023-09-30	1,200,721,959	1,738,700,000	69.06%
2023-06-30	1,190,582,238	1,740,359,000	68.41%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

ABBOTT LABORATORIES (ABT) — SEC Financial Statements & Analysis

ABBOTT LABORATORIES (ABT) is a pharmaceutical preparations company, incorporated in IL. ABBOTT LABORATORIES trades on ABT: NYSE as: ABT. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), ABBOTT LABORATORIES reported a 6.59% year-over-year revenue growth, a Gross Profit Margin of 56.26% (TTM), a Debt-to-Equity ratio of 0.35x, a Price-to-Sales (P/S) ratio of 3.91x (TTM), a Price-to-Book (P/B) ratio of 3.39 (TTM), at a market cap of $176.53B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 6.59%
Gross Profit Margin TTM: 56.26%
Debt To Equity: 0.35x
P/S TTM: 3.91x
P/B TTM: 3.39
Market Cap: $176.53B

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is ABBOTT LABORATORIES in?

ABBOTT LABORATORIES (ABT) operates in the Pharmaceutical Preparations industry.

What is ABT's market cap?

ABBOTT LABORATORIES (ABT) has a market capitalization of $176.53B as of 2026-03-31.

What is ABT's P/E ratio?

ABBOTT LABORATORIES (ABT)'s trailing twelve month P/E ratio is 28.13x as of 2026-03-31.

What exchange does ABT trade on?

ABBOTT LABORATORIES (ABT) trades on the ABT: NYSE.

Where is ABBOTT LABORATORIES incorporated?

ABBOTT LABORATORIES is incorporated in IL.

ABBOTT LABORATORIES (ABT) — SEC Financial Statements & Analysis

Frequently Asked Questions

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.